Benaroya Research Institute at Virginia Mason, Seattle, WA 98101, USA.
J Immunol. 2011 Sep 1;187(5):2061-6. doi: 10.4049/jimmunol.1003224.
Regulatory T cells (Treg) play a dominant role in suppression of autoimmune pathology, as rescue of Treg number and/or function in model systems can both prevent and reverse disease. These findings have generated a series of studies addressing the role of defects in Treg number and function in human autoimmunity. However, demonstrating global defects in Treg of individuals diagnosed with autoimmune diseases has been challenging. These challenges are founded, in part, in the complexity of human autoimmune diseases in which various genetic factors and environmental triggers contribute to disease susceptibility. Moreover, contribution of failed Treg-mediated suppression to pathogenesis can extend to multiple mechanisms. In this article, we discuss what is known with respect to the number and function of CD4(+)FOXP3(+) Treg in human autoimmunity, focusing on representative autoimmunediseases in which there are diverse Treg-mediated defects. We also highlight the need to better understand Treg plasticity and function in the context of autoimmunity.
调节性 T 细胞(Treg)在抑制自身免疫病理学中发挥主导作用,因为在模型系统中挽救 Treg 的数量和/或功能既可以预防又可以逆转疾病。这些发现引发了一系列研究,探讨了 Treg 数量和功能缺陷在人类自身免疫中的作用。然而,证明诊断为自身免疫性疾病的个体的 Treg 存在普遍缺陷具有挑战性。这些挑战部分基于人类自身免疫性疾病的复杂性,其中各种遗传因素和环境触发因素导致疾病易感性。此外,Treg 介导的抑制作用失败对发病机制的贡献可以扩展到多种机制。在本文中,我们讨论了在人类自身免疫中 CD4(+)FOXP3(+)Treg 的数量和功能方面的已知情况,重点介绍了存在多种 Treg 介导缺陷的代表性自身免疫性疾病。我们还强调需要更好地理解自身免疫背景下 Treg 的可塑性和功能。